Tag Archives: JKS

Hot Medical Stocks To Own For 2019

Berkshire Hathaway Chairman and CEO Warren Buffett, right, speaks to Microsoft co-founder and director at Berkshire Hathaway, Bill Gates, as they appear to speak on the Fox Business Network with Liz Claman, in Omaha, Neb., Monday, May 8, 2017. (AP Photo/Nati Harnik)

Just one day after the House of Representatives voted 217-213 to repeal and replace Obamacare, Berkshire Hathaway CEO Warren Buffett came out swinging against the plan and suggested that Congress – and businesses – are focusing on the wrong issues.

At Berkshire Hathaway’s annual shareholders meeting, Buffett suggesting that the rising costs of healthcare, and not taxes, are the top barrier to growth for American businesses. Rather than championing for corporate tax cuts, Buffett posited that corporations would do better to examine the rising costs of healthcare in the country. “Medical costs are the tapeworm of American economic competitiveness ,” he declared.

Hot Medical Stocks To Own For 2019: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    JinkoSolar Holding Company (NYSE:JKS) Q1 2018 Earnings Conference CallJun. 26, 2018 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Travis Hoium]

    Solar stocks took a beating Monday after China cut its national incentives to install solar projects. Shares of solar panel manufacturers Canadian Solar Inc. (NASDAQ:CSIQ) fell as much as 14.5%, JinkoSolar Holding Co. (NYSE:JKS) dropped as much as 17%, and Daqo New Energy Corp (NYSE:DQ) fell as much as 31.3% while inverter manufacturer Enphase Energy Inc (NASDAQ:ENPH) fell up to 13.5%. By early afternoon, most major stocks in the solar industry were down double digits.

  • [By Ethan Ryder]

    JinkoSolar Holding Co., Ltd. (NYSE:JKS)’s share price dropped 5.6% during mid-day trading on Tuesday . The company traded as low as $11.92 and last traded at $12.16. Approximately 987,700 shares traded hands during trading, an increase of 50% from the average daily volume of 659,992 shares. The stock had previously closed at $12.88.

Hot Medical Stocks To Own For 2019: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) reached a new 52-week high and low during trading on Wednesday . The company traded as low as $81.72 and last traded at $81.25, with a volume of 3382 shares traded. The stock had previously closed at $80.34.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Federated Investors Inc. PA raised its holdings in Nu Skin Enterprises, Inc. (NYSE:NUS) by 20.7% during the first quarter, Holdings Channel reports. The institutional investor owned 125,726 shares of the company’s stock after buying an additional 21,522 shares during the quarter. Federated Investors Inc. PA’s holdings in Nu Skin Enterprises were worth $9,267,000 at the end of the most recent quarter.

Hot Medical Stocks To Own For 2019: PennantPark Investment Corporation(PNNT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Garrison Capital (NASDAQ: GARS) and PennantPark Investment (NASDAQ:PNNT) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on PennantPark Investment (PNNT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Live Ventures (NASDAQ: LIVE) and PennantPark Investment (NASDAQ:PNNT) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Hot Medical Stocks To Own For 2019: The Michaels Companies, Inc.(MIK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Michaels Companies (MIK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    The Michaels Companies (Nasdaq: MIK) owns six brands in the retail arts & crafts space, including the top specialty retailer in North America and the #1 wholesale distributor by market share. The arts & crafts segment should hold up well in any kind of consumer weakness as people look to save money by staying in and spending on inexpensive crafts.

  • [By Jim Crumly]

    As for individual stocks, Etsy (NASDAQ:ETSY) made a huge jump after announcing a fee increase for sellers, and The Michaels Companies (NASDAQ:MIK) fell on weak guidance.

  • [By Demitrios Kalogeropoulos]

    The week ahead will likely bring more volatility, particularly for shareholders ofDave & Buster’s(NASDAQ:PLAY), H&R Block(NYSE:HRB), and Michaels(NASDAQ:MIK)as each of these companies is set to announce quarterly earnings results over the next few days. Let’s look at a few key trends to watch for in the reports.

Hot Medical Stocks To Own For 2019: Tejon Ranch Co(TRC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Terracoin (CURRENCY:TRC) traded down 14.6% against the dollar during the 24 hour period ending at 23:00 PM ET on May 17th. In the last week, Terracoin has traded 20.7% higher against the dollar. Terracoin has a market cap of $4.06 million and $4,377.00 worth of Terracoin was traded on exchanges in the last 24 hours. One Terracoin coin can now be bought for about $0.18 or 0.00002218 BTC on popular exchanges including CoinExchange, Trade Satoshi, C-CEX and Cryptopia.

Hot Medical Stocks To Own For 2019: Mechel OAO(MTL)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Chelyabinsk Metallurgical Plant (NYSE:MTL) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Chelyabinsk Metallurgical Plant earned a news impact score of 0.10 on Accern’s scale. Accern also assigned news articles about the basic materials company an impact score of 46.5001512376479 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Max Byerly]

    Mullen Group Ltd (TSE:MTL) reached a new 52-week high on Friday . The company traded as high as C$15.38 and last traded at C$15.38, with a volume of 248494 shares. The stock had previously closed at C$14.72.

  • [By Joseph Griffin]

    Mullen Group Ltd (TSE:MTL) declared a monthly dividend on Wednesday, June 20th, Zacks reports. Shareholders of record on Saturday, June 30th will be paid a dividend of 0.05 per share on Monday, July 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.90%. The ex-dividend date of this dividend is Thursday, June 28th.

Hot Tech Stocks To Invest In 2019

OMB Looks Ready to OK Delay of Fiduciary Rule

Trumps New Labor Pick Acosta Likely to Be More Nuanced Than Puzder

How Behavioral Economics Can Help You Retire Rich

The nine plaintiffs suing the Labor Department over its fiduciary rule in a Texas court said late Friday that they are appealing Judge Barbara M.G. Lynn’s Feb. 8 decision upholding Labor’s rule. 

“We remain confident in the merits and strength of our case and stand by our assertion that the Department of Labor exceeded its authority,” said the plaintiffs, which include the U.S. Chamber of Commerce, the Securities Industry and Financial Markets Association, and the Financial Services Institute, in a joint statement announcing the appeal.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources STRAIGHT-THROUGH PROCESSING FOR THE FINANCIAL SERVICES INDUSTRY

STP can be described as electronically capturing and processing transactions in one pass, from the point of first ‘deal’ to final settlement.

Hot Tech Stocks To Invest In 2019: Sapiens International Corporation N.V.(SPNS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Sapiens International Co. (NASDAQ:SPNS) have earned a consensus rating of “Hold” from the six brokerages that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $12.50.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Sapiens International (SPNS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Sapiens International (NASDAQ:SPNS) issued its quarterly earnings results on Monday. The technology company reported $0.13 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.10 by $0.03, Briefing.com reports. Sapiens International had a net margin of 0.13% and a return on equity of 6.81%. The business had revenue of $71.09 million for the quarter, compared to analyst estimates of $67.68 million. During the same quarter in the prior year, the business posted $0.02 EPS. Sapiens International’s revenue for the quarter was up 25.8% compared to the same quarter last year.

Hot Tech Stocks To Invest In 2019: Cross Country Healthcare, Inc.(CCRN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Cross Country Healthcare (NASDAQ:CCRN) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Wednesday.

  • [By Ethan Ryder]

    Cross Country Healthcare (NASDAQ: CCRN) and StarTek (NYSE:SRT) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

  • [By Joseph Griffin]

    Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received an average recommendation of “Buy” from the thirteen ratings firms that are presently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $14.00.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By ]

    Activist investor Glenn Welling of Engaged Capital LLC, the insurgent investor agitating for changes at TiVo, Rent-a-Center, on Tuesday, May 15, revealed new positions in Aratana Therapeutics Inc. (PETX) , Cross Country Healthcare Inc. (CCRN)  and Finisar Corp. (FNSR)

Hot Tech Stocks To Invest In 2019: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Brian Stoffel]

    Shareholders of Veeva Systems(NYSE:VEEV), a software-as-a-service (SaaS) company that specializes in meeting the needs of the pharmaceutical industry, have enjoyed quite a run. The company has continually outpaced expectations, leading to returns of 260% since February of 2016.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Veeva Systems (VEEV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
    Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
    Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
    Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
    Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
    Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
    Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
    Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
    DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
    8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
    Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
    ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
    Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
    Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
    Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
    Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue

  • [By Leo Sun]

    Shares of Veeva (NYSE:VEEV)have rallied about 40% this year, as the healthcare cloud services provider topped first-quarter analyst estimates with robust sales and earnings growth. Its revenue rose 22% annually to $195.5 million, beating estimates by $6.6 million. Its non-GAAP net earnings grew43% to $0.33 per share, exceeding expectations by $0.02.

  • [By Kristine Harjes]

    In this week’s episode of Industry Focus: Healthcare, host Kristine Harjes interviews Matt Wallach, the co-founder and president of cloud computing companyVeeva Systems(NYSE:VEEV). Veeva serves healthcare companies across the board, from fledgling biotechs to massive stalwarts like Johnson & Johnson, and many investors see big potential for sustainable, long-term growth in the future.

Hot Tech Stocks To Invest In 2019: Live Ventures Incorporated(LIVE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Live Stars (CURRENCY:LIVE) traded up 2.3% against the dollar during the 24 hour period ending at 23:00 PM Eastern on June 25th. Over the last seven days, Live Stars has traded down 10.1% against the dollar. One Live Stars token can currently be bought for approximately $0.0249 or 0.00000400 BTC on major exchanges. Live Stars has a total market cap of $990,922.00 and $25,651.00 worth of Live Stars was traded on exchanges in the last day.

  • [By Ethan Ryder]

    Live Ventures (NASDAQ: LIVE) and PennantPark Investment (NASDAQ:PNNT) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Hot Tech Stocks To Invest In 2019: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By ]

    Tariffs
    Governmental action from the White House has added itself to the mix. In January, President Trump announced steep tariffs on imported solar panels. This did two things: It immediately made U.S.-produced solar panels a little more competitive than low-cost alternatives from China or South Korea. And, two, it has led to a solar manufacturing boom. Foreign companies are simply building factories here, changing the ZIP code on their shipping address and dodging Trump’s import duties without changing a single angle on the engineering specs. Since Mr. Trump announced his tariffs, China’s JinkoSolar (NYSE: JKS) has bought a plant in Jacksonville, Fla., First Solar (Nasdaq: FSLR) added to its manufacturing base in Ohio and SunPower (Nasdaq: SPWR) bought struggling SolarWorld Americas, which had petitioned the president for the tariffs, according to The Wall Street Journal.

  • [By Travis Hoium]

    Solar stocks took a beating Monday after China cut its national incentives to install solar projects. Shares of solar panel manufacturers Canadian Solar Inc. (NASDAQ:CSIQ) fell as much as 14.5%, JinkoSolar Holding Co. (NYSE:JKS) dropped as much as 17%, and Daqo New Energy Corp (NYSE:DQ) fell as much as 31.3% while inverter manufacturer Enphase Energy Inc (NASDAQ:ENPH) fell up to 13.5%. By early afternoon, most major stocks in the solar industry were down double digits.

  • [By Jonathan Schonfeld]

    The Chinese stock market has entered bear market territory. The Shanghai Composite is off more than 20% since January. Ongoing concerns about the nation’s economic growth and a large-scale trade war with the United States have weighed on investor sentiment. This morning, U.S. Treasury Secretary Steven Mnuchin attempted to alleviate concerns about the ongoing selloff by rolling back statements on the nation’s intention to limit domestic Chinese investment. Gold pricestook a beating last week, but sentiment may have finally hit an intermediate-term bottom – and it could make this moment one of the best buying opportunities you’ll see. Money Morning Resource Specialist Peter Krauth explains why now is the time to buy gold. Canada is in the process of legalizing weed, and that’s opening the floodgates for billions of dollars to flow into the industry. On June 19, the Canadian Senate voted to legalize recreational marijuana use. By Oct. 17, Canadian Prime Minister Justin Trudeau wants recreational sales to start, according toCBS. Here’s how you can profit from this event.
    Three Stocks to Watch Today: GE, BHGE, HOG
    General Electric Co.(NYSE: GE) stock popped 5.5% after the company announced a series of spin-off plans on Tuesday. The company said that it will divest its GE Healthcare business and sell its stake in oilfield services giant Baker Hughes Co.(NYSE: BHGE). General Electric, which was recently dropped from the Dow Jones Industrial Average, will now focus exclusively on its aviation, power, and renewable energy businesses. Harley DavidsonInc. (NYSE: HOG) is taking criticism from President Trump. The company recently said it will be moving some of its U.S. production abroad due to tariffs from the European Union. The iconic motorcycle giant had previously said that tariffs would add an additional $2,200 in cost to every motorcycle that it sold. Trump threatened the company earlier today, stating that if it moves operations over sea, “they

Hot Tech Stocks To Invest In 2019: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Ethan Ryder]

    B. Riley started coverage on shares of ChannelAdvisor (NYSE:ECOM) in a report published on Tuesday, MarketBeat.com reports. The firm issued a buy rating and a $17.50 price target on the software maker’s stock. B. Riley also issued estimates for ChannelAdvisor’s Q2 2018 earnings at ($0.21) EPS, Q3 2018 earnings at ($0.11) EPS, Q4 2018 earnings at $0.03 EPS, FY2018 earnings at ($0.41) EPS, Q1 2019 earnings at ($0.09) EPS, Q2 2019 earnings at ($0.11) EPS, Q3 2019 earnings at ($0.04) EPS, Q4 2019 earnings at $0.07 EPS and FY2019 earnings at ($0.16) EPS.

  • [By Shane Hupp]

    ChannelAdvisor (NYSE: ECOM) and Tyler Technologies (NYSE:TYL) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.

4 Solar Stocks to Buy Now

A new day is dawning. As solar energy gets cheaper, it is spreading rapidly around the world, and many countries are preparing to spend a great deal of money on it. In addition to the fact that it is much cleaner than oil, solar energy also creates many jobs and eliminates the need for developing countries to undertake costly extensions of the electricity grid to remote areas.

Furthermore, as I’ve mentioned in the past, the proliferation of electric cars should make the solar energy business more lucrative. Given all of these positive catalysts, I think it’s likely that solar energy prices will stabilize — i.e. stop going down rapidly — very soon.

Meanwhile, the cost of producing solar energy should keep dropping, causing solar energy companies to become much more profitable. By buying First Solar, Inc. (NASDAQ:FSLR), JinkoSolar Holding Co., Ltd. (NYSE:JKS), SunPower Corporation (NASDAQ:SPWR) and SolarEdge Technologies Inc (NASDAQ:SEDG), investors should be able to profit tremendously from these trends.

Solar Stocks to Buy: First Solar (FSLR) Solar Stocks to Buy: First Solar (FSLR)Source: U.S. Department of the Interior via Flickr

The main reason I like First Solar stock, in addition to its ability to benefit from the general positive trends I described above, is its ability to benefit from Saudi Arabia’s gargantuan upcoming investments in solar energy.

It appears that First Solar previously agreed to supply 2.36 million solar modules for a project led by Saudi Arabia’s ACWA Power in the country of Dubai which is located next to Saudi Arabia.  Earlier this year, ACWA won a bid for a much smaller, 300 megawatt solar energy project in Saudi Arabia. The fact that ACWA won the previous deal, and has worked with First Solar in the recent past, suggests that  ACWA and First Solar will make a great deal of money from Saudi Arabia’s upcoming solar projects.

Additionally, as many others have noted, First Solar will benefit from its existing U.S. factory which will allow it to avoid U.S. tariffs, and it recently raised its 2018 shipping guidance, citing strong demand for its modules.

Solar Stocks to Buy: SunPower (SPWR) Solar Stocks to Buy: SunPower (SPWR)Source: via SunPower

SunPower has several attributes that make the outlook for the company and SunPower stock especially positive. The company’s solar panels are known as some of the most efficient in the industry.

It has a major presence in three of the world’s largest and fastest growing solar markets: India, Japan, and the U.S.  Although the company’s fourth-quarter results were hit hard by the tariffs that President Donald Trump placed on the sector, SunPower is countering by launching a factory in the U.S., and it may receive an exemption from the tariffs. SunPower also has a very strong business in South America, and it signed a deal to provide a significant amount of solar panels to NextEra Energy Inc (NYSE:NEE), which owns a number of electric utilities in the U.S.

Assuming that the latter deal goes well, NextEra could expand its dealings with SunPower, and other U.S. utilities could look to sign similar deals with SPWR. News tends to travel fast within sectors, and companies emulate moves by their colleagues and competitors that work well.

One reason for the low price of SunPower is the large amount of debt it’s carrying. But the company’s sale of its stake in renewable company 8point3 Energy should alleviate this problem. Moreover, French energy giant Total SA (NYSE:TOT) owns a majority stake in SunPower, and would be able to kick in additional cash if necessary to prevent the solar company from facing a near-term cash crunch until the solar sector really starts booming.

Solar Stocks to Buy: JinkoSolar (JKS) Solar Stocks to Buy: JinkoSolar (JKS)Source: Russ Ferriday via Flickr (Modified)

JinkoSolar’s sales have boomed in recent years , partly because its solar panels are quite affordable and efficient. But as PvTech pointed out, the company also has “maintained its gross margins in the 10%-20% range” and has “a global sales operations capable of winning opportunities in all key end markets.”

Indeed, according to the publication, in 2017 JinkoSolar ranked “number two in the Chinese and Japanese markets, third in India, fourth in the U.S., and top-rank in Europe and the all-other category.”

Meanwhile, JinkoSolar signed a huge deal with Nex Era. As with SunPower, there’s a decent chance that if NextEra is pleased with JinkoSolar’s modules, it will expand the deal and other U.S. utilities will look to buy JinkoSolar’s panels, boosting JKS stock.

Solar Stocks to Buy: SolarEdge (SEDG) Solar Stocks to Buy: SolarEdge (SEDG)Source: Shutterstock

As I mentioned in a previous column, SolarEdge has strong technology and impressive partners and has delivered great financial results.  Since I wrote the previous column, Deutsche Bank issued a fairly bullish note about SolarEdge stock.

After meeting with the company’s management, the firm wrote that “Concerns over increased competition from Huawei and potential risks of a slowdown in 2018 industry volumes are fading, ” The Fly reported. Deutsche Bank raised its price target on the stock to $57 from $45 but kept a Hold rating on the shares.

But given SolarEdge’s strong growth and the relatively low valuation of SolarEdge stock,  along with Deutsche Bank’s bullish outlook, the firm’s “hold” rating seems illogical. Specifically, SolarEdge’s EPS jumped more than 150% year-over-year last quarter, while it’s trading at less than 20 times analysrs’ forward earnings estimate.

As of this writing, Larry Ramer owned shares of SunPower stock, JinkoSolar stock, and SolarEdge stock. 

Compare Brokers

Hot Performing Stocks To Own Right Now

In Johnson & Johnson news, the stock is down 1.3% over the last five trading days, and that makes this the perfect time to buy this dividend aristocrat…

The pullback was caused by two analysts downgrading Johnson & Johnson (NYSE: JNJ) on July 21, but analysts simply don’t know how to value JNJ stock.

BTIG Research downgraded JNJ from “Neutral” to “Sell” because it doesn’t think Johnson & Johnson will be able to successfully execute its medical device acquisition.

Alembic Global Advisors downgraded the company from “Neutral” to “Underperforming” but didn’t release its rationale.

Hot Performing Stocks To Own Right Now: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Todd Campbell]

    The PARP battle is on. Following news that AstraZeneca’s (NYSE:AZN) PARP-inhibiting cancer drug Lynparza delivered a big win in phase 3 studies, all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity for competitor Tesaro Inc. (NASDAQ:TSRO).

  • [By Ben Levisohn]

    Shares of Tesaro (TSRO) are soaring today after the biotech company reported positive data for its treatment of ovarian cancer over the weekend. Credit Suisse analyst Alethia Young and team contend that “M&A remains in focus” for Tesaro following the data:

    Getty Images

    We are increasing our target price to $122 from $90 as we move to an M&A DCF valuation. We were at ESMO this weekend, and we believe the big takeaway on Tesaro data is that it works broadly in all 2L ovarian populations and safety looks solid. We also think the robustness of this data bodes well from PRIMA and QUADRA but are maintaining our POS here. We have looked at our model and also adjusted durations in first-line. We think Tesaro remains one of the most attractive and de-risked cancer assets in our landscape and the company has been cited in major press sources as a takeout target (Bloomberg, Investor Business Daily).

    We think M&A remains in focus for Tesaro. Our M&A DCF valuations range from $122 to $157 by our model. We have also built models for other cancers like NSCLC, SCLC, prostate, and others where PARP might be impactful. We assume 0% POS for now but we conservatively see at least another $1B in sales from PARP expansion. Tesaro has been cited in the press as a potential M&A target and is a company we frequently hear mentioned as a target from our conversations. We think the demand for late stage oncology assets is high, especially in the PARP space given the potential for activity across a range of tumors. For a large Pharma player who already has an oncology salesforce and large R&D infrastructure we could see SG&A synergies of 50-75% and R&D synergies of 15-30%. In our base case TSRO P&L we model a tax rate of 30% so there could be synergies here as well. Two additional key swing factors which might be included in a CVR are how much expansion from PARP in other cancers and immuno-oncology…

    Ex M&A,

  • [By Todd Campbell]

    Tesaro’s (NASDAQ:TSRO)ovarian cancer drug, niraparib, will begin competing for prescriptions earlier than expected. Niraparib, which will be sold under the brand name Zejula, notched FDA approval on Monday, more than three months ahead of its June 30 decision date. The early approval setsTesaro up for a fierce battle for market share withAstraZeneca (NYSE:AZN)and Clovis Oncology (NASDAQ:CLVS), both of which market drugs that work similarly to Zejula.

  • [By Ben Levisohn]

    Look out below! Shares of Tesaro (TSRO) have dropped more than 10% this afternoon after AstraZeneca (AZN) released stronger-than-expected Phase 3 trial data on a its ovarian cancer treatment.

    Agence France-Presse/Getty Images

    The Street’sAdam Feuerstein has the details on AstraZeneca’s strong data and its impact on Tesaro:

    AstraZeneca’s (AZN) PARP inhibitor Lynparza delayed the recurrence of ovarian cancer by more than two years compared to a placebo, according to results from a phase III study presented Tuesday.

    The strong benefit observed with Lynparza as ovarian cancer maintenance therapy exceeded investor expectations and bolsters AstraZeneca against a competing PARP inhibitor from Tesaro (TSRO).

    Feuerstein also notes that AstraZeneca’s data could be good newsClovis Oncology (CLVS), which also had a PARP inhibitor approved recently, if it means that its drug could work as well as Astra’s.

    In February, Leerink cut Tesaro, arguing that the rally in its shares due to a potential takeover had run too far. Will it still be a takeover target?

    Shares of Tesaro have dropped 14% to $148.01 at 3:28 p.m. today, while AstraZeneca has gained 1.1% to $30.41, and Clovis Oncology has jumped 9.8% to$66.55.

    UPDATE:Piper Jaffray’sSteven Breazzano andJoshua Schimmer note that the AstraZeneca data shows that PARPs are “more similar than different.” They explain:

    This afternoon AstraZeneca (covered by PJC analyst Richard Purkiss) reported the detailed results from the SOLO-2 maintenance study of Lynparza in 2L+ ovarian cancer. The detailed data highlights a PFS benefit of 14 months (investigator assessed, and primary endpoint) and 25 months (blinded central review) over placebo, and favorable hazard ratio of 0.30 and 0.25, respectively, confirming our view that the PARP’s are more similar than different. As such, we believe this provides a favorable readth

  • [By Ben Levisohn]

    Guggenheim’s Tony Butler and Kaitlin Sandor argue that Gilead Sciences (GILD) should buy Syndax Pharmaceuticals (SNDX), Corvus Pharmaceuticals (CRVS), and Tesaro (TSRO) to solve its problem of slowing sales:

Hot Performing Stocks To Own Right Now: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Lisa Levin]

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

    Fuwei Films (Holdings) Co (NASDAQ: FFHL) dropped 9.66% to $1.30. Fuwei Films’ trailing-twelve-month ROE is -10.85%.

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

  • [By Paul Ausick]

    But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the markets hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

Hot Performing Stocks To Own Right Now: Xcel Energy Inc.(XEL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Wednesday that it has raised its rating on Xcel Energy Inc (XEL).

    The firm has upgraded XEL from “Hold” to “Buy,” and has raised the company’s price target from $31 to $32.50. This new price target suggests a 15% upside from the stock’s current price of $27.72.

    Analyst Paul B. Fremont commented: “The stock is currently trading at an 8% P/E discount to our 2015E group average multiple.”

    “Despite a difficult political environment in Minnesota the company was able to achieve a reasonable outcome in its NSP-Minnesota rate case,” the analyst added.

    Looking forward, the firm has increased its FY2014 outlook from $1.95 to $2.00 per share.

    Xcel Energy shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

Hot Stocks To Watch Right Now

JPMorgan (JPM) ended lower Thursday, despite reporting better-than-expected first-quarter earnings.

Bloomberg

The bank said it earned $1.65 a share, above the $1.52 analysts were expecting.Revenue came in at $25.59 billion, above the $24.88 billion consensus.

A couple of analysts are weighing in on the stock. CFRA’s CathySeifert reiterated a Buy rating on the stock:

We keep our 12-month target of $98, 14.9X our ’17 EPS estimate of $6.57 (raised by $0.10) and 13.2X our ’18 EPS estimate of $7.45 (raised by $0.20), close to peers.JPMreported Q1 EPS of $1.65 vs. $1.35, $0.17 above our estimate and $0.14 above the S&P Capital IQ consensus. Results reflected buybacks, plus a 28% drop in the provision for credit losses. Revenues rose a healthy 6.2%, despite 1.3% lower consumer banking revenues on 18.5% lower mortgage revenue and a 3.3% drop in card revenues. We remain encouraged by margins, and strength in corporate and commercial bank units.

Hot Stocks To Watch Right Now: One Horizon Group, Inc.(OHGI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Hot Stocks To Watch Right Now: Nomura Holdings Inc ADR(NMR)

Advisors’ Opinion:

  • [By Maureen Farrell]

    Shortly after Lehman declared bankruptcy, Barclays (BCS) paid $1.3 billion for most of the firm’s North American operations, its Times Square headquarters, and about 9,000 employees. Nomura Holdings (NMR) paid roughly $200 million for Lehman’s operations in Asia.

Hot Stocks To Watch Right Now: (LGEAF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    However, Apple is turning to LG (OTC:LGEAF) and the Herald reports that Apple is even considering investing in a future plant in China to build flexible displays. It’s thought that the bendable displays could be available as early as 2019.

  • [By SEEKINGALPHA.COM]

    The importance of cellular connectivity for wearables, particularly for smartwatches, has been a theme of mine since last year, and I’m glad to see other analysts and organizations starting to pick up on it. I’ve discussed Qualcomm’s (NASDAQ:QCOM) development of the Snapdragon Wear SOC that manufacturers are using for Android Wear 2 smartwatches with LTE connectivity, such as the LG Watch Sport (OTC:LGEAF). Such watches provide voice calling and cellular data connections and anticipate the future direction of the smartwatch.

  • [By SEEKINGALPHA.COM]

    There are other areas of smartphone innovation pursued by other companies besides Apple. The development of OLED screens has been a significant innovation pursued mainly by Korean giants Samsung (OTC:SSNLF) and LG (OTC:LGEAF). It is now being reported that Samsung and LG will introduce smartphones with foldable OLED screens this year.

Hot Stocks To Watch Right Now: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Paul Ausick]

    But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the markets hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.

  • [By Lisa Levin]

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

    Fuwei Films (Holdings) Co (NASDAQ: FFHL) dropped 9.66% to $1.30. Fuwei Films’ trailing-twelve-month ROE is -10.85%.

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

  • [By Paul Ausick]

    It is not often that a secondary stock offering sends a companys shares higher, but we are seeing that very phenomenon Friday morning. Chinese solar PV maker JinkoSolar Holding Co. Ltd. (NYSE: JKS) and stock image company Shutterstock Inc. (NASDAQ: SSTK) both priced secondary offerings this morning and shares in both companies have risen sharply.

Hot Stocks To Watch Right Now: Freeport-McMoran, Inc.(FCX)

Advisors’ Opinion:

  • [By ]

    Major turning points like the one were seeing right now can generate spectacular comeback moves. In fact, were already witnessing several of these rallies in our commodity-centric plays. Just look at copper miner Freeport-McMoRan Inc. (NYSE: FCX).

  • [By Jon C. Ogg]

    The metals and mining sector has seen many winners, particularly in steel and copper. Freeport-McMoRan Inc. (NYSE: FCX) is big in copper and shares were last seen down 0.3% at $13.90 late on Monday, which might have been up more had it been less diversified. Shares of Freeport-McMoRanare up 26% in the past fivetrading days. The stock has a market cap of $18 billion.

  • [By Reuben Gregg Brewer]

    In February, the shortest month of the year, copper, gold, and oil company Freeport-McMoRan Inc (NYSE:FCX) saw its shares tumble by nearly 20%. After a roughly 95% price gain in 2016, it was a painful reminder of years past, when Freeport-McMoRan was dealing with the aftermath of an ill-timed oil investment.

  • [By Reuben Gregg Brewer]

    Freeport-McMoRan Inc. (NYSE:FCX) and Barrick Gold (NYSE:ABX) rank among the largest gold and copper miners in the world. After years of retrenching, both are in better operational and financial shape than they were when commodity prices started to tumble in 2011. But now that metals prices are finally rising, there are new troubles to face. Barrick’s headwinds, however, don’t look nearly as formidable as what Freeport-McMoRan is facing.

  • [By WWW.KIPLINGER.COM]

    Some energy stocks just cant seem to catch a break and Freeport-McMoRan Inc. (FCX) is one of those energy stocks. As we all know, FCX made some bad moves and decided to get into the oil business just as prices were peaking. That wouldnt be so bad, if it wasnt for the massive debt it took out to buy stakes in the gulf and other regions.